Losartan Potassium Tablet, Film Coated
Product Images NDC 70518-4773

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 70518-4773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Losartan Structure)

Chemical structure of losartan potassium, showing the arrangement of atoms and bonds including potassium ion (K+), chlorine, nitrogen atoms, and characteristic functional groups relevant to this active ingredient.*

FDA Label Image

Fig-1 (Losartan Fig 1)

A line graph comparing the percentage of patients with primary endpoints over study months between Losartan potassium and Atenolol. The graph shows % patients on the y-axis and study months on the x-axis, illustrating adjusted risk reduction data with statistical significance noted (13%, p=0.021).*

FDA Label Image

Fig-2 (Losartan Fig 2)

A line chart comparing the percentage of patients with fatal or non-fatal stroke over 66 months in two groups: one treated with Losartan Potassium and the other with Atenolol. The graph shows adjusted risk reduction for Losartan Potassium at 25%, with a p-value of 0.001, illustrating lower stroke incidence in the Losartan Potassium group consistently throughout the study duration.*

FDA Label Image

Fig-3 (Losartan Fig 3)

A forest plot chart comparing hazard ratios with 95% confidence intervals for Losartan potassium versus Atenolol. It shows event rates by patient demographics and conditions (age, gender, race, ISH, diabetes, history of cardiovascular disease) for primary composite outcomes and stroke outcomes (fatal/non-fatal). The horizontal axis indicates favoring Losartan potassium on the left and Atenolol on the right.*

FDA Label Image

Fig-4 (Losartan Fig 4)

A line graph comparing the percentage of patients with an event over 48 months for Losartan potassium versus placebo. The solid line represents Losartan potassium, and the dashed line represents placebo. The chart indicates a 16.1% risk reduction with Losartan potassium, with a p-value of 0.022.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Losartan Potassium 100 mg film-coated tablets, quantity 100, repackaged by RemedyRepack Inc. It includes storage instructions to protect from light and keep out of children's reach, with temperature storage details. Manufacturer is Novadoz Pharma LLC, Piscataway, NJ. The label shows NDC 70518-4773-00 and states 'RX ONLY.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.